Mycolic acids are major components of the cell wall of Mycobacterium tuberculosis.
Introduction
Tuberculosis remains a leading cause of mortality world-wide, with approximately 2 million people dying of the disease in 1997 (1) . It is estimated that one-third of the world population is infected with the causative pathogen, Mycobacterium tuberculosis. The persistent phase of infection is one of the hallmarks of tuberculosis, when the bacteria are thought to be in a Structures of mycolic acid cyclopropane synthases slow-growing or non-growing state (2) . There are many effective anti-tuberculosis drugs which target actively growing bacteria in cell processes such as cell wall biogenesis and chromosomal replication (3) . However, these drugs are not as effective against persistent bacteria and this is typically why lo ng multidrug therapies of 6 to 9 months are required to treat TB. Long-term therapies have lead to patient non-compliance and in turn contributed to the emergence of multidrug resistant TB (MDR-TB) (4) . This points to an urgent need for new anti-mycobacterials, particularly therapies effective against persistent bacteria which could clear infection rapidly reducing treatment times.
Given this priority for the discovery of new anti-tuberculosis drugs, interest has been focused on a family of proteins which are involved in modifications of mycolic acids, very longchain lipids that are found either covalently attached to the cell wall or in the form of cord factor (trehalose dimycolate), and have been demonstrated to be important in the persistent phase of infection. Recently, Glickman et al. reported results of a mutagenesis screen which selected for cording mutants and identified a mutation in umaA2 (Rv0470c-unknown in mycolic acid methyl transfer). Aside from its defect in cording, a phenotype often associated with pathogenicity, umaA2 was also shown to be required for long-term mycobacterial persistence and virulence (5) .
Characterization showed that the umaA2 mutant had alterations in a major class of mycolic acids of the cell wall. Indeed, umaA2 showed high homology to S-adenosyl-L-methionine-dependent methyltransferases (SAM-dependent methyltransferases) 1 called cyclopropane synthases.
Mycobacteria have an unusual cell wall in which mycolic acids play a critical role in its structure and function. Important characteristics conferred by this structure are resistance to chemical injury, low permeability to antibiotics, resistance to dehydration and ability to thrive within the hostile environment of the macrophage phagolysosome (6) . Mycolic acids of mycobacteria are long-chain α-alkyl, β-hydroxy fatty acids containing 70-90 carbons in total (6) (7) (8) . The α-branch is a saturated alkyl chain, typically 24 carbons long. The meromycolate chain contains 40-60 carbons with two positions of modification: the distal position (close to the ω-end) and the proximal position (close to the β-hydroxy end). There are three classes of mycolic acids synthesized by M. tuberculosis called α-, keto-, and methoxymycolates, which are classified according to their modifications at these two positions (Fig. 1a) . The α-mycolates have a cis cyclopropane ring at both positions, whereas keto-and methoxymycolates have oxygenated groups at the distal position and a cyclopropane ring at the proximal position which can be in either a cis or trans conformation.
The first protein to be identified from M. tuberculosis involved in carrying out these modifications at either the distal or proximal position of mycolic acids was a cyclopropane mycolic acid synthase (cmaA1) (9) . It was identified based on its homology to the E. coli enzyme CFA synthase (10). The enzyme from E. coli had previously been shown to be a SAMdependent methyltransferase, which catalyzed the addition of a methyl group to a double bond of an acyl chain of the phosphoslipid bilayer, resulting in the formation of a cyclopropane ring (10).
When CmaA1 was expressed in Mycobacterium smegmatis it was shown that a cyclopropane ring was introduced at the distal position of the mycolic acids (9) .
Structures of mycolic acid cyclopropane synthases
Since then at least 7 other homologous genes have been identified in the genome sequence of H37Rv (11) . They are cmaA2 (Cyclopropane Mycolic Acid synthase 2), mmaA1-4 (MethoxyMycolic Acid synthase) and umaA1-2 (Unknown Mycolic Acid methyltransferase).
These genes share between 50 and 75% identity with each other and are all thought to be SAMutilizing methyltransferases. CmaA2 encodes a protein which cyclopropanates at the proximal position of mycolic acids when heterologously expressed in M. smegmatis (12) . Further studies in M. tuberculosis have confirmed that CmaA2 modifies the proximal position, specifically catalyzing the formation of a trans cyclopropane ring of keto-and methoxymycolates (13) .
UmaA2 was shown to be required for the synthesis of the proximal cyclopropane ring of the α-mycolates and was so renamed PcaA (Proximal cyclopropanation of alpha-mycolates) (5). It is thought that MmaA2, which also synthesizes a proximal cis cyclopropane ring, acts on the methoxymycolates (14, 15) . MmaA1 is believed to catalyze the conversion of a cis to trans doub le bond at the proximal position (16) , while MmaA3 and MmaA4 are required for the formation of oxygen-containing mycolates at the distal position (14, 15, 17, 18) .
Cyclopropanation of mycolic acids is a modification associated with pathogenic mycobacteria and is not common in the cell wall of saprophytic species such as M. smegmatis (19) . In addition to the recent demonstration of the importance of a cyclopropane synthase, PcaA, in virulence and persistence of tuberculosis, other studies show that cyclopropane ring modifications have profound effects on the resistance of the mycobacteria to the oxidative stress (9) and the fluidity and permeability of the cell wall (12, 16, 17 For protein expression, cell cultures were grown in LB or terrific broth at 16-20 °C throughout. 0.5 mM IPTG was added for induction when cell density reaches an OD600 of ~0.9.
Cell cultures were incubated for another 24 hours before harvest. Expression of se-PcaA and seCmaA1 was achieved as above except that minimal media with selenomethionine was used. DTT and 1 mM EDTA were used for purification. Purified recombinant proteins were concentrated to > 5 mg ml -1 , flash-frozen, and stored at -80 °C prior to crystallization.
Crystallization
Crystals were obtained by either hanging drop vapor diffusion method (PcaA, CmaA2) or microbatch method (CmaA1) using paraffin oil. 7-10 mg ml 
Data collection
The MAD data of the se-CmaA1-SAH-CTAB and se-PcaA-SAH were collected at beamline 14-BM-D on an ADSC Q4 CCD area detector at the Advanced Photon Source (APS),
Argonne National Laboratory (ANL). CmaA1-SAH-DDDMAB and CmaA2-SAH-DDDMAB crystals were collected at 1.0 Å at beamline 14-BM-C, APS, ANL. The crystals were flashfrozen in a liquid nitrogen stream at 100 °K. Paratone-N (Hampton) was used as a cryoprotectant for CmaA1 and PcaA, and paraffin oil was used for CmaA2. The diffraction data of apo-CmaA1 crystal was collected on a NONIUS/MACSCIENCE/DIP2030 image plate detector, using a Rigaku rotating anode X-ray source with Cu K α radiation. The crystal was flash-frozen at 120 °K. All data were processed and reduced using DENZO and SCALEPACK (25).
Structure determination and refinement
Structures of se-CmaA1-SAH-CTAB and se-PcaA-SAH were solved using MAD phasing 
Results and Discussion
Overall structure of the cyclopropane synthases CmaA1, CmaA2 and PcaA (Fig. 2 a,b) . The core region of all three proteins contains a seven-stranded β sheet with α helices flanking on either side. The β-sheet is made up of parallel β strands except for β7, which is antiparallel to the neighboring strands, β5 and β6. The arrangement of the β strands is β3-β2-β1-β4-β5-β7-β6. α helices on both sides of the central β sheet are aligned nearly parallel to the β sheet and have the same N-to C-orientation. This seven-stranded α/β fold is similar to other SAM-MTases (35) (36) (37) . Consistent with this, a structural similarity search in DALI (38) shows highest scores for SAM-MTases (Z ≥ 7.8 σ), followed by nucleotide-binding proteins, including many NAD-dependent dehydrogenases and reductases (Z ≥ 4.6 σ). The cofactor SAM/SAH binding site is located at the C-terminal ends of the β strands in the same position in which the cofactor is located in other methyltransferases.
The cofactor SAM/SAH binding site
The cofactor SAM/SAH binding pocket is nearly identical in the 3 proteins and is composed of several regions: the loop between β1 and α4 (motif I), the loop between β2 and α5
(motif II), the loop between β3 and α6 (motif III), α7 (motif IV), N-terminal α1, and the loop between α1 and α2 (Fig. 4a , Table 2 ). The interactions between SAH and CmaA1 are listed in Table 2 . Structural comparison and primary sequence analysis of the cyclopropane synthases and other SAM-MTases show that motif I, II, and III are highly conserved in cofactor binding sites ( Fig. 4a) (36, 37, 39) . Motif I, which contains a glycine-rich consensus sequence, is the most highly conserved. Motif IV exists in some SAM-MTases but is less well conserved. From the orientation of the cofactor relative to the protein, it is clear that the interactions between these motifs and the cofactor are also conserved: motif I binds the amino acid moiety and the ribose; motif II binds the ribose and adenine ring; and motif III binds the adenine ring of SAM/SAH.
The interactions between the adenine ring and the protein involve both hydrogen bonds and van der Waals interactions. The 2' and 3' hydroxyl groups of the ribose moiety, as well as the amino acid moiety, are held in position by extensive hydrogen bonds ( Table 2 , Fig. 4a ). The Nterminus, although not forming direct interactions with the cofactor, is hydrogen bonded to α7/α8 sequestering the SAM/SAH binding pocket and making it inaccessible to solvent. It is possible that in order for the enzyme to turnover, the first ~20 N-terminal amino acids need to go through a conformational change for the exchange of the product SAH and the substrate SAM.
Indeed, the electron density for the first 18 amino acid residues at the N-terminus was unclear in the structure of apo-CmaA1, suggesting that the N-terminus may be flexible in the absence of cofactor.
Acyl substrate binding site
In the center of the loop between β5 and α11 (residues 170-210), a tunnel extends from the surface to the cofactor binding site. This tunnel is ~15 Å long and ~ 10 Å wide and is observed in all three proteins. Amino acid residues in the cavity are exclusively hydrophobic, suggesting that this region is where acyl substrate binds. This was substantiated by the structures of CmaA1
and CmaA2 in complex with SAH and CTAB/DDDMAB.
In the structure of CmaA1-SAH-CTAB, the presence of CTAB in the active site of CmaA1 was confirmed in an experimental electron density map and the modeled lipid refined with good geometry (Fig. 2c) . CTAB contains a 16-carbon long alkyl chain with a positively charged quaternary ammonium group at one end. It binds to CmaA1 in a U-shape conformation with two bends at C8 and C12, generating a ~5-7 alkyl chain on each side of the U-shaped CTAB (Fig.   2c ). DDDMAB binds to CmaA1 in the same pocket as CTAB. The positively charged quaternary ammonium group binds in the same place in both structures, indicating the binding of this functional group is specific. DDDMAB also adapts a U-shaped manner, but bends one of its alkyl chains inside the lipid-binding pocket, unlike CTAB which makes the turns near the entrance of the cavity (Fig. 3b) . The interactions between the alkyl chain of the lipid and the protein are exclusively hydrophobic interactions, including Ile169, Leu192, Ile195, Phe200, Leu205, Tyr232, Le u236, Phe273, Ile278, and Glu140. The positively charged quaternary ammonium group sits on top of α7, surrounded by several aromatic rings: Tyr16, Tyr33, Tyr232, and Tyr265. Most of these residues are conserved in all three proteins, indicating that the lipid binds to them in a similar way. Indeed, DDDMAB binds to CmaA2 almost identically to CmaA1 (Fig. 4c) . The distance from the ends of the alkyl chain of DDDMAB to the surface is ~ 9 Å, suggesting that the protein can accept much longer alkyl chains.
The structure of apo-CmaA1
The overall fold of apo-CmaA1 is similar to the structure of CmaA1-SAH-DDDMAB with RMS deviation of C α atoms of 0.78 Å for the α/β fold excluding residues 137-144. A superimposition of structures of apo-CmaA1 and CmaA1-SAH-DDDMAB ternary complex is shown in Fig. 3a . Residues 137-144, which form a two-turn helix in the ternary complex (α7), is a loop in the apo-CmaA1 structure. Because of this conformational change, the loop between β5
and α11 (residues 170-210) of apo-CmaA1 mo ves ~ 5-10 Å away from the cofactor binding site.
α12-14 (residues 230-270) are also slightly shifted (~ 1-4 Å). As already mentioned, the first 18 amino acids at the N-terminus are not visible in the electron density maps, suggesting that this region is more flexible in the absence of cofactor.
Residues 137-144 (α7 in the ternary complex structure) is part of motif IV involved in cofactor SAM/SAH binding. The loop conformation in the apo-CmaA1 structure enlarges the cofactor binding pocket (Fig. 3b) , and also separates the cofactor binding site from the lipid binding site in the apo structure. It is in contrast to the ternary complex structure where α7 sits in the middle of the cofactor and lipid binding pockets (Fig. 3b) , forming a narrow channel ~ 5 Å wide connecting these two substrate binding sites. Movement of residue 170-210 away from the active site moves the lipid binding pocket closer to the surface and also makes it shallower (Fig.   3b ). It is apparent that the protein undergoes a large conformational change upon formation of ternary complex.
The mechanism of the cyclopropanation reaction
In SAM-MTases, the methyl transfer reaction either proceeds through a nucleophilic (45), and glycine-N-methyltransferase (46) . There are a number of difficulties in studying the activity of cyclopropane synthases in vitro, such as the insolubility of long acyl chain, the unavailability of long acyl chain commercially and the fact that the real substrate is likely to be acyl-AcpM. For these reasons the detailed mechanism of CmaA1, CmaA2 or PcaA has not been studied. It is proposed that the reaction goes through a mechanism similar to N-and O-methyltransferases, where the methyl group is transferred to the double bond, forming a carbocation intermediate (6, 20) . A proton abstraction from the methyl group will lead to the formation of a cyclopropane
Structures of mycolic acid cyclopropane synthases ring, while the addition of an oxygen atom by nucleophilic attack of water would lead to the formation of oxygen-containing functional groups on mycolic acids.
The structure of CmaA1-SAH-DDDMAB supports this mechanism for several reasons. (Fig. 4c) (43, 47) . Specifically, the aromatic ring of Tyr33 faces the N atom at a distance of 4.9 Å, providing a perfect orientation for such interactions (Fig. 4c ).
Additional electron density was observed in the active site of all three enzymes, which was unexpected. This was assigned as a bicarbonate ion based on its planar, trigonal shape and its hydrogen bonding pattern, rather than an acetate ion, which could have been present from the crystallization solution. The three oxygen atoms of the bicarbonate interact with NE of His167 (O1), backbone amide NH of Cys35 (O1), OE1 of Glu140 (O2), backbone amide NH of Ile169 (O2), and -OH group of Tyr232 (O3) (Fig. 4c) . The function of this bicarbonate is not clear, but a possible role is to abstract the proton from the methyl group to complete the cyclopropanation reaction. O3 of the bicarbonate is only 3.1 Å away from one methyl group of DDDMAB. The low pK a of carbonic acid also supports the possibility that the bicarbonate io n is a general base.
In addition, examination of the active site residues shows that all the amino acids near the active Structures of mycolic acid cyclopropane synthases site with the potential to be a general base are conserved in the homologs which catalyze the cyclopropanation reaction and the homolo gs which catalyze the formation of the oxygencontaining functional groups. Most interestingly, Gly137 on α7, right below the bicarbonate ion, is conserved in all homologs which catalyze the cyclopropanation reaction (CmaA1, CmaA2, MmaA2, and PcaA), while in the homologs involved in the formation of oxygen-containing groups (MmaA3 and MmaA4) it is a glutamate. If a glutamate side chain is modeled at residue 137, the carboxyl group of the glutamate is in close proximity to the lipid, where it may function as a general base using a water molecule for nucleophilic attack.
Comparison of the structure of two proximal cyclopropane synthases
CmaA2 and PcaA both catalyze cyclopropanation at the proximal position of the meromycolate chain. In the case of PcaA, it has been shown to be required for synthesis of the proximal cis cyclopropane ring of α-mycolates (5). For CmaA2, initial results suggested that this was also a proximal cyclopropanating enzyme. Expression of the cmaA2 gene in M.
smegmatis resulted in the enrichment of proximal cis cyclopropane ring on α 1 -mycolates (α 1 -mycolates contain two unsaturated double bonds at both the distal and the proximal positions) (12) . However, disruption of the cmaA2 gene in M. tuberculosis causes the lack of a proximal trans cyclopropane ring on keto-and methoxymycolates (13) , therefore suggesting that its true role in M. tuberculosis is to catalyze cyclopropanation of the proximal trans olefins. As well as their clearly distinct biosynthetic roles, these proteins are also functionally nonredundant. PcaA was identified as a gene necessary for the morphology of cording in M. tuberculosis, however inactivation of cmaA2 does not affect cording in M. tuberculosis (data not shown). Therefore it is likely that each member of the mycolic acid cyclopropane synthase gene family serves a distinct function in the interaction of mycobacteria with its host.
Sequence alignments show 59% identity and 68% similarity between PcaA and CmaA2.
The mode of cofactor binding is also shown to be almost identical for PcaA and CmaA2. Also hydrophobic residues around the lipid binding pocket, as well as those residues in the active site, are conserved between the two proteins, indicating that these two enzymes probably catalyze their reactions in the same way. There are however two regions specifically where PcaA differs from CmaA2. Firstly, CmaA2 has eight additional amino acids at its N-terminus and secondly, has an insertion of seven amino acids of residues 152 to 160, corresponding to residues 144 and 145 of PcaA. Electron density at the N-terminus of CmaA2 was unclear and the first 11 amino acids were unable to be built into the model. Therefore it remains unclear whether the extended N-terminus has a role in designating specificity towards a trans-olefin. The 7 amino acid insertion corresponding to residues 152 to 160 of CmaA2 forms an extra loop between α7 and α8, which sits on the outside of the enzyme away from the active site. This insert forms at least two additional hydrogen bonds with the N-terminus (Fig. 4b) , when compared to CmaA1.
Although the function of these interactions is not known, the exchange of the cofactor may be more difficult in CmaA2. It seems likely from the structure of CmaA2 bound to DDDMAB that this enzyme can accommodate either a cis or trans double bond, due to the flexibility of the alkyl chain. This is consistent with experimental observations which suggest that CmaA2 exhibits a certain lack of substrate specificity with respect to cis versus trans cyclopropanation (12, 13) .
Indeed specificity may be determined by the availability of the trans-olefin substrate. Whether this 7 amino acid insertion is directly involved in specifying a preference for trans over cis reactivity is not clear. Future mutagenesis experiments may help determine the role of these regions, if any, in specificity.
Comparison of the structures of the proximal versus distal cyclopropane synthases
CmaA2 and PcaA both catalyse the addition of a cyclopropane ring to the proximal olefin of mycolic acids (5, 12, 13) . CmaA1, on the other hand, is believed to catalyze cis cyclopropanation at the distal position of the α-mycolates based on its expression in M.
smegmatis (9) . Superimposition of the structures of CmaA2, PcaA and CmaA1 shows that there is little difference in the overall three-dimensional fold of these enzymes (Fig. 2a) . However there is one region in which the proximal and distal enzyme differ, that is, α9 is in a different conformation in CmaA1 compared to both PcaA and CmaA2 (Fig. 2a) . α9 forms part of the region of these enzymes (residues 170-210 in CmaA1 and PcaA and residues 195-225 in CmaA2) where the entry point to the lipid binding pocket sits. Close examination of the molecular surfaces of the three proteins reveals a common feature adjacent to the entrance to the hydrophobic tunnel (Fig. 5 ). There is a basic/hydrophobic patch constituted by the loop between β5 and α11 in all three structures. Although the amino acids are not strictly conserved, two regions of basic charges are conserved among CmaA1, CmaA2, PcaA and the other homologs (Fig. 5) .
Comparison of the cyclopropane synthases with other acyl-ACP ut ilizing enzymes
Examination of other acyl-ACP utilizing enzymes reveals a similar constellation of basic residues leading to the hypothesis that these residues constitute the ACP binding site. Acyl The pattern of basic side chains surrounding a hydrophobic patch in CmaA1, CmaA2 and
PcaA is very similar to the pattern observed in AcpS (Fig. 5) , suggesting that this region is possibly where AcpM binds to the cyclopropane synthases. Examination of the three structures reveals that α9 in the proximal cyclopropane synthases is shifted ~ 5 Å with respect to that region in the distal cyclopropane synthases. Based on this being the proposed AcpM binding site, we envisage a mechanism of distal versus proximal substrate specificity determined by the conformation of the enzyme between β5 and α11. In the proximal enzymes this region forms a planar surface. This may allow the acyl-AcpM to sit closer to the active site, favoring the reaction at the proximal position. By contrast, in the distal enzyme AcpM would sit on a domed, protruded part of the surface, so increasing the distance to the active site and so favoring a reaction at the distal position in the acyl chain. The idea of substrate specificity based on the differing lengths of the substrate binding cavity has also been proposed for isoprenoid substrate specificity in protein farnesyltransferase (51) and farnesyl diphosphate synthase (52).
PcaA has clearly been shown to be essential for maintenance of a chronic infection. This suggests that the family of mycolic acid methyltransferases may have particular importance in virulence and persistence of M. tuberculosis. As there are no known cyclopropanated lipids in mammals, we believe that these structures together with biochemical assays, will provide a foundation for the rational development of new inhibitors. Moreover, the similarity of these enzymes in their active site suggests the possibility that one inhibitor may be effective against multiple targets, reducing the potential for drug resistance, a desirable feature for any new drug in the fight against TB. 
